Reshetnikov O.V.,Research Institute of Therapy |
Openko T.G.,Research Institute of Therapy |
Simonova G.I.,Research Institute of Therapy |
Kurilovich S.A.,Research Institute of Therapy |
And 3 more authors.
Voprosy Onkologii | Year: 2012
In a prospective study the risk of subsequent gastric cancer (GC) was assessed in persons aged 45-69 over 5 years after the initial testing with a set of serological tests (pepsinogen I, pepsinogen II, gastrin-17, antibodies to Helicobacter pylori). The presence of gastric atrophy markers was a significant predictor of GC in the forthcoming years. Non-invasive techniques may be used in the formation of high-risk groups, followed by GC active surveillance.